EFFECTS OF MAXIMALLY TOLERATED ORAL-THERAPY ON THE 6-MINUTE WALKING TEST IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO EITHER ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY
A. Gualeni et al., EFFECTS OF MAXIMALLY TOLERATED ORAL-THERAPY ON THE 6-MINUTE WALKING TEST IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO EITHER ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY, The American journal of cardiology, 81(11), 1998, pp. 1370
In patients with heart failure, therapy with ''maximally tolerated'' o
ral doses of diuretics, vasodilators, and digitalis results in a signi
ficant increase in the distance walked during the B-minute walking tes
t, compared with conventional therapy at ''standard'' doses, indicatin
g an improvement in exercise tolerance. The 6-minute walk test is a si
mple, inexpensive, and well-tolerated test to measure changes in exerc
ise tolerance induced by pharmacologic interventions, even on a short-
term basis.